Category: Influenza
Global Influenza
-
Global Zika Virus Testing Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most ... Read More
-
Global Zika Virus Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika ... Read More
-
Global Zika Virus Testing Market Size, Manufacturers, Opportunities and Forecast to 2030
... Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are ... Read More
-
Global Influenza Diagnostics Databank Market Report
... 2029. RT-PCR segment is expected to be the highest contributor to this market, with $339.2 Million in 2020, and is anticipated to reach $425.1 Million by 2029, registering a CAGR of 2.58%. Cell Culture segment ... Read More
-
Global Ebola Virus Infection Market - 2024-2031
... the forecast period 2024-2031. Ebola virus disease formerly known as ebola haemorrhagic fever is a severe often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals such as ... Read More
-
Global Avian Influenza Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Avian Influenza Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Avian Influenza Vaccines. The report also introduces players ... Read More
-
Vaccines Market By Technology Type (Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), By Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, and Rubella, Diphtheria, Pertussis, and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035
... and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035 The vaccine market was valued at $43.2 billion in 2023 and is projected to reach ... Read More
-
Influenza Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 7.97 billion in 2023, and the market is now projected to grow from USD 8.55 billion in 2024 to USD 17.77 billion by 2032, exhibiting a CAGR of 9.6% during the forecast period of 2024-2032. ... Read More
-
2024 Global Forecast for Influenza Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Biological Safety Testing Market Size, Trends, Analysis, and Outlook By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, 2024-2030
... Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, ... Read More
-
West Nile Virus Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Antivirals, Vaccines, Antibiotics, Analgesics, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global West Nile Virus Therapeutics market size is poised to register 2.83% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
The 2025-2030 World Outlook for Human Influenza Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for H1N1 2009 Influenza Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Influenza Medications
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Influenza Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Influenza
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Influenza Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Zanamivir Influenza Medications
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Communicable Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Influenza Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Global Influenza Vaccination Market Growth (Status and Outlook) 2024-2030
... market, the Influenza Vaccination is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Influenza Vaccination ... Read More
Research Assistance
